Cargando…

Effectiveness of the e-Tabac Info Service application for smoking cessation: a pragmatic randomised controlled trial

OBJECTIVE: To compare the effectiveness of the mobile e-Tabac Info Service (e-TIS) application (app) for helping adult smokers quit smoking with current practices. DESIGN: Pragmatic randomised controlled trial with a 1-year follow-up (2017–2018). SETTING: France, population-wide level. PARTICIPANTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Affret, Aurélie, Luc, Amandine, Baumann, Cédric, Bergman, Pierre, Le Faou, Anne-Laurence, Pasquereau, Anne, Arwidson, Pierre, Alla, François, Cambon, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592285/
https://www.ncbi.nlm.nih.gov/pubmed/33109670
http://dx.doi.org/10.1136/bmjopen-2020-039515
_version_ 1783601154888826880
author Affret, Aurélie
Luc, Amandine
Baumann, Cédric
Bergman, Pierre
Le Faou, Anne-Laurence
Pasquereau, Anne
Arwidson, Pierre
Alla, François
Cambon, Linda
author_facet Affret, Aurélie
Luc, Amandine
Baumann, Cédric
Bergman, Pierre
Le Faou, Anne-Laurence
Pasquereau, Anne
Arwidson, Pierre
Alla, François
Cambon, Linda
author_sort Affret, Aurélie
collection PubMed
description OBJECTIVE: To compare the effectiveness of the mobile e-Tabac Info Service (e-TIS) application (app) for helping adult smokers quit smoking with current practices. DESIGN: Pragmatic randomised controlled trial with a 1-year follow-up (2017–2018). SETTING: France, population-wide level. PARTICIPANTS: 2806 adult smokers who wished to quit smoking were recruited via the website of the French National Mandatory Health Insurance fund. Of them, 1400 were randomised to the e-TIS app arm and 1406 were randomised to the current practices arm (control). INTERVENTION: The app involved personalised interactive contacts that included questionnaires, advice, activities and text messages. All contacts were individually tailored and based on each smoker’s progress. In the control group, recommended practices for quitting smoking were described on a non-interactive website. PRIMARY AND SECONDARY OUTCOMES MEASURES: The primary outcome was 7-day point prevalence abstinence (PPA) at 6 months. The secondary outcomes included continuous abstinence rates at 6 and 12 months, minimum 24-hour point abstinence at 3 months, minimum 30-day point abstinence at 12 months and number and duration of quit attempts. RESULTS: There was no difference between the e-TIS and control arms for the primary outcome (12.6% vs 13.7% for 7-day PPA at 6 months, p=0.3949, intention-to-treat analysis). However, e-TIS participants with high levels of exposure to the app, which was defined by the completion of at least eight activities or questionnaires, showed higher rates of smoking cessation than the control participants (17.6% vs 12.9% for 7-day PPA at 6 months, p=0.0169, per-protocol analysis). CONCLUSION: Use of the e-TIS app was not associated with a higher rate of smoking cessation. However, high level of exposure to the e-TIS app may have been more effective than current practices. TRIAL REGISTRATION NUMBER: NCT02841683.
format Online
Article
Text
id pubmed-7592285
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-75922852020-10-29 Effectiveness of the e-Tabac Info Service application for smoking cessation: a pragmatic randomised controlled trial Affret, Aurélie Luc, Amandine Baumann, Cédric Bergman, Pierre Le Faou, Anne-Laurence Pasquereau, Anne Arwidson, Pierre Alla, François Cambon, Linda BMJ Open Public Health OBJECTIVE: To compare the effectiveness of the mobile e-Tabac Info Service (e-TIS) application (app) for helping adult smokers quit smoking with current practices. DESIGN: Pragmatic randomised controlled trial with a 1-year follow-up (2017–2018). SETTING: France, population-wide level. PARTICIPANTS: 2806 adult smokers who wished to quit smoking were recruited via the website of the French National Mandatory Health Insurance fund. Of them, 1400 were randomised to the e-TIS app arm and 1406 were randomised to the current practices arm (control). INTERVENTION: The app involved personalised interactive contacts that included questionnaires, advice, activities and text messages. All contacts were individually tailored and based on each smoker’s progress. In the control group, recommended practices for quitting smoking were described on a non-interactive website. PRIMARY AND SECONDARY OUTCOMES MEASURES: The primary outcome was 7-day point prevalence abstinence (PPA) at 6 months. The secondary outcomes included continuous abstinence rates at 6 and 12 months, minimum 24-hour point abstinence at 3 months, minimum 30-day point abstinence at 12 months and number and duration of quit attempts. RESULTS: There was no difference between the e-TIS and control arms for the primary outcome (12.6% vs 13.7% for 7-day PPA at 6 months, p=0.3949, intention-to-treat analysis). However, e-TIS participants with high levels of exposure to the app, which was defined by the completion of at least eight activities or questionnaires, showed higher rates of smoking cessation than the control participants (17.6% vs 12.9% for 7-day PPA at 6 months, p=0.0169, per-protocol analysis). CONCLUSION: Use of the e-TIS app was not associated with a higher rate of smoking cessation. However, high level of exposure to the e-TIS app may have been more effective than current practices. TRIAL REGISTRATION NUMBER: NCT02841683. BMJ Publishing Group 2020-10-27 /pmc/articles/PMC7592285/ /pubmed/33109670 http://dx.doi.org/10.1136/bmjopen-2020-039515 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Public Health
Affret, Aurélie
Luc, Amandine
Baumann, Cédric
Bergman, Pierre
Le Faou, Anne-Laurence
Pasquereau, Anne
Arwidson, Pierre
Alla, François
Cambon, Linda
Effectiveness of the e-Tabac Info Service application for smoking cessation: a pragmatic randomised controlled trial
title Effectiveness of the e-Tabac Info Service application for smoking cessation: a pragmatic randomised controlled trial
title_full Effectiveness of the e-Tabac Info Service application for smoking cessation: a pragmatic randomised controlled trial
title_fullStr Effectiveness of the e-Tabac Info Service application for smoking cessation: a pragmatic randomised controlled trial
title_full_unstemmed Effectiveness of the e-Tabac Info Service application for smoking cessation: a pragmatic randomised controlled trial
title_short Effectiveness of the e-Tabac Info Service application for smoking cessation: a pragmatic randomised controlled trial
title_sort effectiveness of the e-tabac info service application for smoking cessation: a pragmatic randomised controlled trial
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592285/
https://www.ncbi.nlm.nih.gov/pubmed/33109670
http://dx.doi.org/10.1136/bmjopen-2020-039515
work_keys_str_mv AT affretaurelie effectivenessoftheetabacinfoserviceapplicationforsmokingcessationapragmaticrandomisedcontrolledtrial
AT lucamandine effectivenessoftheetabacinfoserviceapplicationforsmokingcessationapragmaticrandomisedcontrolledtrial
AT baumanncedric effectivenessoftheetabacinfoserviceapplicationforsmokingcessationapragmaticrandomisedcontrolledtrial
AT bergmanpierre effectivenessoftheetabacinfoserviceapplicationforsmokingcessationapragmaticrandomisedcontrolledtrial
AT lefaouannelaurence effectivenessoftheetabacinfoserviceapplicationforsmokingcessationapragmaticrandomisedcontrolledtrial
AT pasquereauanne effectivenessoftheetabacinfoserviceapplicationforsmokingcessationapragmaticrandomisedcontrolledtrial
AT arwidsonpierre effectivenessoftheetabacinfoserviceapplicationforsmokingcessationapragmaticrandomisedcontrolledtrial
AT allafrancois effectivenessoftheetabacinfoserviceapplicationforsmokingcessationapragmaticrandomisedcontrolledtrial
AT cambonlinda effectivenessoftheetabacinfoserviceapplicationforsmokingcessationapragmaticrandomisedcontrolledtrial